Skip to main content
MJFF Feed

Parkinson's Disease Research in 2012 – How Far We’ve Come and What Lies Ahead: On Demand!

Parkinson's Disease Research in 2012 – How Far We’ve Come and What Lies Ahead: On Demand!

On Thursday, December 13th, The Michael J. Fox Foundation (MJFF) hosted the final event of the year in its Hot Topics in Parkinson’s disease (PD) Research Seminar Series: "PD Research 2012: How Far We’ve Come and What Lies Ahead.” The webinar, which is now available on demand, was led by MJFF CEO Todd Sherer, PhD, and Associate Director of Research Programs Maurizio Facheris, MD, MSc.

During the one-hour event, Sherer highlighted important research progress made this past year, while providing a wide view of the advances made in the field since the Foundation's inception in 2000. Sherer also looked ahead to exciting projects and critical milestones expected in the year to come.

Sherer and Facheris also answered participants’ questions live, covering specific questions about certain drug candidates, while also addressing what people living with PD can do today. Stay tuned for a Q&A blog post where Sherer and Facheris will answer more of your questions. And once you've checked out the webinar, you can share your feedback on the session in this brief survey. You can also view the webinar slides (without audio) at the bottom of this page.     

Those interested in learning more about Parkinson’s disease research on their own should check out the “Understanding Parkinson’s” section of our Web site. And follow our blog, Foxfeed, for all of the latest updates in PD research.

To find out more about how you can participate in clinical trials, and to see your own potential trial matches, visit www.foxtrialfinder.org.

And, lastly, please stay tuned for upcoming Hot Topics webinars in 2013. We’re planning an engaging program!

Parkinson's Disease Research 2012 from MichaelJFoxOrg

 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.